IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

August 6-7, 2019

Cambridge Health Institute’s (CHI) 4th Annual Oncolytic Virus Immunotherapy Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Systemic OV Therapy Using Voyager-V1”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com